Search results
Results from the WOW.Com Content Network
In 2009 the government of Mexico created a regulatory pathway for genetically modified maize, [85] but because Mexico is the center of diversity for maize, gene flow could affect a large fraction of the world's maize strains. [86] [87] A 2001 report in Nature presented evidence that Bt maize was cross-breeding with unmodified maize in Mexico. [88]
This is an accepted version of this page This is the latest accepted revision, reviewed on 13 January 2025. Foods produced from organisms that have had changes introduced into their DNA Part of a series on Genetic engineering Genetically modified organisms Bacteria Viruses Animals Mammals Fish Insects Plants Maize/corn Rice Soybean Potato History and regulation History Regulation Substantial ...
The best way to avoid pesticides, if that’s a health concern, is to go with organic food, as unlike organic foods, conventional, non-GMO foods are still likely exposed to pesticides.
MON 832 is an herbicide tolerant maize under license from Monsanto. MON 863 is an Insect Resistant maize under license from Monsanto. [7] MON-8746Ø-4 (MON87460) is a water use efficient maize under license from Monsanto produced for human consumption and livestock feed. [8]
You’ll find this sticker on all grocery store produce.
Maize and cornmeal (ground dried maize) constitute a staple food in many regions of the world. [6] Maize is used to produce the food ingredient cornstarch. [98] Maize starch can be hydrolyzed and enzymatically treated to produce high fructose corn syrup, a sweetener. [99] Maize may be fermented and distilled to produce Bourbon whiskey. [100]
Getty Images About 20 years ago, a company now owned by Monsanto (MON) introduced the Flavr Savr tomato -- the first genetically modified organism approved for consumption in the United States.
In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed [5] and in 2006 for use in food. [6] There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr Gilles-Éric Séralini, who was on the committee that reviewed MON863 for the French government.